Goldman Sachs’s CARGO Therapeutics CRGX Stock Holding History

Goldman Sachs’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-235,412	Closed	-$970K	–	6379
2025 Q2	$970K	Buy	235,412 +18,653	+9%	+$79.9K	﹤0.01%	4730
2025 Q1	$882K	Sell	216,759 -13,793	-6%	-$92.4K	﹤0.01%	4783
2024 Q4	$3.32M	Buy	230,552 +4,420	+2%	+$80.2K	﹤0.01%	3844
2024 Q3	$4.17M	Buy	226,132 +135,519	+150%	+$2.42M	﹤0.01%	3504
2024 Q2	$1.49M	Buy	90,613 +59,862	+195%	+$1.14M	﹤0.01%	4154
2024 Q1	$686K	Buy	30,751 +18,375	+148%	+$437K	﹤0.01%	4573
2023 Q4	$287K	Buy	+12,376	New	+$210K	﹤0.01%	5030

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's CRGX Position: Q3 2025 in Review

Goldman Sachs sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 235,412 shares — an estimated $970K sold.

Goldman Sachs first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $4.17M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Goldman Sachs reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Goldman Sachs sold 235,412 CARGO Therapeutics shares in Q3 2025, an estimated $970K.
Goldman Sachs first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Goldman Sachs's CARGO Therapeutics position peaked at $4.17M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.